This Indefinite Delivery Contract (IDC) was awarded by the National Acquisition Center, a division of the Department of Veterans Affairs (VA), to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company based in Boca Raton, Florida. The single-award, unrestricted contract has a ceiling value of $18,098,362.00 and a period of performance from March 2, 2021 to March 1, 2026. The contract is for the delivery of Pregabalin capsules, a generic pharmaceutical product, to the VA,...
This indefinite delivery contract was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Xlcare Pharmaceuticals, Inc. to supply gabapentin capsules in various package sizes to meet the estimated annual needs of the VA, Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The single-award, indefinite delivery contract has a total ceiling value of $54,110,891.35 and a base period of performance from November 11, 2023 through November...
The federal contract IDV award is for the delivery of Cyclobenzaprine HCL Tablets to multiple federal healthcare agencies, including the Department of Veterans Affairs (VA), Department of Defense (DoD), Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The single-award, unrestricted contract was issued by the VA National Acquisition Center and has a base period of one year with four one-year option periods, for a total potential period of performance through June 2, 2036....
The federal agency, the Department of Veterans Affairs (VA) National Acquisition Center, has awarded an Indefinite Delivery Contract (IDC) to Golden State Medical Supply, Inc., a for-profit pharmaceutical manufacturer and distributor based in Camarillo, California. The contract, valued at a ceiling of $4,663,495.34, is for the procurement of Phenytoin Sodium (NA) Extended 100MG Sustained Action (SA) Capsules. The contract will serve multiple federal agencies, including the VA, Department of...
The Department of Veterans Affairs (VA) National Acquisition Center awarded Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company, a single-award Indefinite Delivery Contract (IDC) for the supply of pharmaceutical products, including ibuprofen, under the agency's Pharmaceutical Repackaging Program. The contract has a ceiling value of $15,582,998.52 and a period of performance from June 20, 2022 to June 19, 2025. Under this IDC, the VA has issued multiple firm...
The Department of Veterans Affairs (VA) National Acquisition Center awarded a single-award, unrestricted Indefinite Delivery Contract (IDC) to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company based in Boca Raton, Florida. The contract, valued at a ceiling of $48,442,917.75, is for the supply of Escitalopram Oxalate Tablets in various package sizes to the VA, Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The contract has a...
The federal contract IDV award is for the delivery of Topiramate tablets to the Department of Veterans Affairs (VA), Department of Defense (DoD), Bureau of Prisons, and Indian Health Service. The single-award, unrestricted contract was issued by the VA National Acquisition Center, with a total ceiling value of $32,360,809.00 and a period of performance from October 31, 2020 to October 30, 2025. The prime contractor, Exelan Pharmaceuticals Inc., is a foreign-owned, for-profit pharmaceutical...
This Indefinite Delivery Contract, awarded by the U.S. Department of Veterans Affairs (VA) National Acquisition Center to Exelan Pharmaceuticals Inc., provides for the delivery of Zonisamide capsules in various dosages to the VA, Department of Defense (DoD), Bureau of Prisons, and Indian Health Service. The single-award, firm fixed-price contract has a period of performance from June 15, 2021 to June 14, 2022, with four one-year option periods, for a total ceiling value of $8,974,952.04....
The Department of Veterans Affairs (VA) National Acquisition Center awarded an Indefinite Delivery Contract (IDC) to Xlcare Pharmaceuticals Inc., a minority-owned, small disadvantaged business, to provide Oxcarbazepine pharmaceutical products. The single-award IDC has a base period of performance from October 14, 2024 to October 13, 2025, with four one-year option periods, for a total potential contract value of $11,065,099.45. The contracted items will be distributed through the VA's and...
This indefinite delivery contract (IDC) was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Xlcare Pharmaceuticals Inc., a minority-owned, small disadvantaged business and economically disadvantaged woman-owned small business. The contract has a ceiling value of $18,554,214.00 and a period of performance from May 24, 2021 to May 23, 2022, with four one-year option periods. The contract is for the supply of levetiracetam tablets to the VA, Department of Defense...